Completed
Myeloma Treatment in Real Life
NCT03638232
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
Not specified
Clinical trial condition
Multiple Myeloma
Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.
1,662 public trials
323 recruiting studies
Multiple Myeloma trial results
NCT01852799
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Shanghai Changzheng Hospital Shanghai, Shanghai Municipality, China
NCT00064337
- Conditions
- Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +18 more
- Locations
-
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- University of California Davis Cancer Center Sacramento, California, United States
- Mountain States Tumor Institute at St. Luke's Regional Medical Center Boise, Idaho, United States
- Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center Kansas City, Kansas, United States
NCT00701103
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
Not specified
NCT01428492
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Novartis Investigative Site Scottsdale, Arizona, United States
- Novartis Investigative Site Duarte, California, United States
- Novartis Investigative Site Atlanta, Georgia, United States
- Novartis Investigative Site Chicago, Illinois, United States
NCT01690143
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- UAB Birmingham, Alabama, United States
- Memorial Sloan Kettering Cancer Center New York, United States
- Medical University of South Carolina Hollings Cancer Center Charleston, South Carolina, United States
- Medical College of Wisconsin Milwaukee, Wisconsin, United States
Completed
Melphalan, Prednisone and Thalidomide Versus Melphalan and Prednisone in Elderly Myeloma Patients
NCT00232934
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease, +15 more
- Locations
-
- Divisionedi Ematologia - Ospedali Riuniti Bergamo, Italy
- Istituto di Ematologia e Oncologia Medica "Seragnoli"- Università di Bologna Bologna, Italy
- Divisione di Ematologia - Az. Osp. S.Croce Carle Cuneo, Italy
- U.O. di Ematologia e Trapianto di Cellule Staminali, IRCCS Casa Sollievo della Sofferenza Foggia, Italy
NCT02206503
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
- Locations
-
- Policlinico Umberto I Rome, Italy
Completed
Phase 2 Multi-center Study of Anti-PD-1 During Lymphopenic State After HDT/ASCT for Multiple Myeloma
NCT02331368
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
- Medical College of Wisconsin Milwaukee, Wisconsin, United States
NCT02071888
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +20 more
- Locations
-
- Mayo Clinic Scottsdale, Arizona, United States
- Colorado Blood Cancer Institute Denver, Colorado, United States
- Winship Cancer Institute of Emory School of Medicine Atlanta, Georgia, United States
- John Theruer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States